These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24848259)

  • 1. Acridine and its derivatives: a patent review (2009 - 2013).
    Zhang B; Li X; Li B; Gao C; Jiang Y
    Expert Opin Ther Pat; 2014 Jun; 24(6):647-64. PubMed ID: 24848259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acridine derivatives: a patent review (2009 - 2010).
    Kaur J; Singh P
    Expert Opin Ther Pat; 2011 Apr; 21(4):437-54. PubMed ID: 21323399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interest of acridine derivatives in the anticancer chemotherapy.
    Demeunynck M; Charmantray F; Martelli A
    Curr Pharm Des; 2001 Nov; 7(17):1703-24. PubMed ID: 11562307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acridine and acridone derivatives, anticancer properties and synthetic methods: where are we now?
    Belmont P; Bosson J; Godet T; Tiano M
    Anticancer Agents Med Chem; 2007 Mar; 7(2):139-69. PubMed ID: 17348825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
    Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1997 Jun; 40(12):1919-29. PubMed ID: 9191970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
    Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
    Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
    Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
    J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
    Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The structural and functional analysis of the biological activity of acridine derivatives].
    Deeva EG; Pavlovskaia IaV; Kiselev OI; Kiselev VI; Piotrovskiĭ LB; Ershov FI
    Vestn Ross Akad Med Nauk; 2004; (2):29-34. PubMed ID: 15101206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review on Acridines as Antiproliferative Agents.
    Baliwada A; Rajagopal K; Varakumar P; Raman K; Byran G
    Mini Rev Med Chem; 2022; 22(21):2769-2798. PubMed ID: 35546777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfur Containing Acridine Derivatives in Preclinical Studies with Cancer Cell Lines.
    Othman S; Kozurkova M
    Curr Med Chem; 2018; 25(17):1968-1975. PubMed ID: 28413957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and properties of bioactive 2- and 3-amino-8-methyl-8H-quino[4,3,2-kl]acridine and 8,13-dimethyl-8H-quino[4,3,2-kl]acridinium salts.
    Hutchinson I; McCarroll AJ; Heald RA; Stevens MF
    Org Biomol Chem; 2004 Jan; 2(2):220-8. PubMed ID: 14737646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on acridinylthioureas and its derivatives: biological and cytotoxic activity.
    Kožurková M; Sabolová D; Kristian P
    J Appl Toxicol; 2017 Oct; 37(10):1132-1139. PubMed ID: 28370171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-binding antitumor agents: from pyrimido[5,6,1-de]acridines to other intriguing classes of acridine derivatives.
    Antonini I
    Curr Med Chem; 2002 Sep; 9(18):1701-16. PubMed ID: 12171552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel synthetic acridine derivatives as potent DNA-binding and apoptosis-inducing antitumor agents.
    Lang X; Li L; Chen Y; Sun Q; Wu Q; Liu F; Tan C; Liu H; Gao C; Jiang Y
    Bioorg Med Chem; 2013 Jul; 21(14):4170-7. PubMed ID: 23735826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antileishmanial activities of 4,5-di-substituted acridines as compared to their 4-mono-substituted homologues.
    Carole DG; Michel DM; Julien C; Florence D; Anna N; Séverine J; Gérard D; Pierre TD; Jean-Pierre G
    Bioorg Med Chem; 2005 Oct; 13(19):5560-8. PubMed ID: 16081295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
    Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
    J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acridine: a versatile heterocyclic nucleus.
    Kumar R; Kaur M; Kumari M
    Acta Pol Pharm; 2012; 69(1):3-9. PubMed ID: 22574501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linker-modified triamine-linked acridine dimers: synthesis and cytotoxicity properties in vitro and in vivo.
    Wang SS; Lee YJ; Hsu SC; Chang HO; Yin WK; Chang LS; Chou SY
    Bioorg Med Chem; 2007 Jan; 15(2):735-48. PubMed ID: 17107806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,3-Dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: synthesis, biological evaluation, and structure-activity relationships.
    Antonini I; Polucci P; Kelland LR; Menta E; Pescalli N; Martelli S
    J Med Chem; 1999 Jul; 42(14):2535-41. PubMed ID: 10411474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.